In addition, our study demonstrated the unique epidemiological characteristics of HER2-low patients comparing with those with HER2-negative or positive tumors and suggested the discordance between CNB and SEB might be more inclined to occur in patients with advanced N stages and some other specific tumor characteristics, but more potential influencing factors remained to be explored. Here, ERBB2 is linked to neoplasm.